Ethambutol
To view the entire topic, please log in or purchase a subscription.
The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:
-- The first section of this topic is shown below --
General Principles
- Ethambutol (15–25 mg/kg PO q24h or 50–75 mg/kg PO twice a week; maximum, 2.4 g/dose) is bacteriostatic and inhibits arabinosyltransferase (involved in cell wall synthesis).
- Doses should be reduced in the presence of renal dysfunction.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
General Principles
- Ethambutol (15–25 mg/kg PO q24h or 50–75 mg/kg PO twice a week; maximum, 2.4 g/dose) is bacteriostatic and inhibits arabinosyltransferase (involved in cell wall synthesis).
- Doses should be reduced in the presence of renal dysfunction.
There's more to see -- the rest of this entry is available only to subscribers.